FILE:DVA/DVA-8K-20081028170242.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers	Financial Statements and Exhibits
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 
 
 
 
Effective December 31, 2008, Joseph C. Mello will retire as Chief Operating Officer of DaVita Inc. (the "Company"). Mr. Mello will continue with the Company on a full-time basis through May 2009 and on a part-time basis thereafter. A copy of the press release announcing Mr. Mello's retirement is attached hereto as Exhibit 99.1.
Dennis Kogod, the Company's President-West, will become the Company's Chief Operating Officer effective January 1, 2009. Mr. Kogod, age 49, has served as the Company's President-West since October 2005. From January 2004 until joining us, Mr. Kogod served as President and Chief Operating Officer-West of Gambro Healthcare, Inc., which the Company acquired in October 2005. From July 2000 to January 2004, Mr. Kogod served as President, West Division of Gambro Healthcare, Inc. From June 1999 to July 2000, Mr. Kogod was President of Teleflex Medical Group, a medical OEM manufacturer of medical delivery systems. From January 1996 to June 1999, Mr. Kogod was Corporate Vice President of Teleflex Surgical Group, a surgical device and service organization. Mr. Kogod serves on the board of directors of Arbios Systems, Inc., a medical device and cell-based therapy company.
The material terms of Mr. Kogod's employment agreement dated as of October 31, 2005, effective October 24, 2005, were described in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 4, 2005 and are incorporated herein by reference. There are no family relationships between Mr. Kogod and any other director or executive officer of the Company, or with any person selected to become an officer or a director of the Company. The Company has had no transactions since the beginning of its last fiscal year, and has no transactions proposed, in which Mr. Kogod, or any member of his immediate family, has a direct or indirect material interest.
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 28, 2008
 
 
 
 

Exhibit 99.1
 
EL SEGUNDO, CA, October 23, 2008, DaVita Inc. (NYSE: DVA), today announced that Joe Mello will retire as the company's Chief Operating Officer on December 31, 2008. Dennis L. Kogod has been promoted to Chief Operating Officer effective January 1, 2009. Dennis currently serves as DaVita's President  West, a role he has occupied since October 2005.
Joe Mello, who served as Chief Operating Officer since June 2000, will continue with the company on a full-time basis through May 2009 and on a part-time basis thereafter.
Dennis joined DaVita in 2005, following DaVita's acquisition of Gambro Healthcare, Inc. From January 2004 until joining DaVita, Mr. Kogod served as Gambro's president and chief operating officer-west.
Kent Thiry, Chief Executive Officer of DaVita, commented: "This planned succession is yet another in the long list of wonderful contributions Joe Mello has made to the DaVita community. Our immense gratitude for Joe's historical contributions is matched by our confident anticipation of the future contributions Dennis will make. When we acquired Gambro a few years ago we added many new assets to our enterprise  the leadership of Dennis was among the most valuable. In addition, both Dennis and I are thrilled that we will still benefit from Joe's experience in select areas going forward."
DaVita Inc. is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages over 1,300 outpatient facilities and acute units in over 700 hospitals located in 43 states and the District of Columbia, serving more than 107,000 patients.


